Skip to main content
Cisen Pharmaceutical Co.,Ltd. logo

Cisen Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 603367 ISIN · CNE100002VG4 LEI · 836800T7RRJXURVHYS35 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,110 across all filing types
Latest filing 2025-01-24 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 603367

About Cisen Pharmaceutical Co.,Ltd.

https://www.cisen-pharma.com/

Cisen Pharmaceutical Co.,Ltd. is a comprehensive enterprise dedicated to the research, development, production, and marketing of a diverse range of medicinal products. The company specializes in the manufacture of large-volume injections, small-volume injections, and solid oral dosage forms, including tablets and capsules. Its product portfolio addresses critical therapeutic areas such as parenteral nutrition, anti-infectives, cardiovascular health, and anesthesia. Cisen Pharmaceutical maintains an integrated value chain, producing both active pharmaceutical ingredients (APIs) and finished formulations. The organization emphasizes technological innovation and stringent quality management systems to ensure the efficacy and safety of its medical solutions. By leveraging advanced manufacturing capabilities and a robust distribution network, the company provides essential healthcare products to clinical institutions and medical providers.

Recent filings

Filing Released Lang Actions
辰欣药业股份有限公司2025年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2025 first extraordinary general meeting of shareholders of the company. It includes information about the meeting date, location, attendance, voting results on specific proposals, and legal witness statements. It does not contain financial statements or detailed financial analysis but focuses on the voting outcomes and procedural compliance of the shareholder meeting. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is under 5,000 characters but contains substantive voting results, so it is not merely a report publication announcement. Therefore, the correct classification is DVA with high confidence.
2025-01-24 Chinese
辰欣药业股份有限公司关于股东大会开设网络投票提示服务的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (776 characters) regarding the provision of a network voting reminder service for an upcoming shareholder meeting (an Extraordinary General Meeting on January 24, 2025). It references a prior notice about the meeting (announcement 2025-004) and explains how shareholders can receive reminders and vote electronically. There is no financial data, no detailed report, and no voting results disclosed here. The document serves to inform shareholders about the voting facilitation service rather than the meeting materials or results themselves. According to the classification rules, such announcements about meeting logistics and voting services fall under Regulatory Filings (RNS) as they do not constitute AGM Information (AGM-R) or Declaration of Voting Results (DVA).
2025-01-16 Chinese
辰欣药业股份有限公司2025年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the "2025 First Extraordinary General Meeting of Shareholders" of a company. It includes detailed meeting instructions, agenda, and two main proposals: one about a change in accounting estimates and another about the election of a non-independent director. The document contains detailed procedural information about the meeting, voting methods, and legal compliance. It is not a financial report like an annual or interim report, nor is it a transcript or earnings release. It is not a simple announcement of voting results but rather the meeting materials including agenda and proposals to be voted on. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or Extraordinary General Meeting. The document length (6043 characters) and content confirm it is the meeting materials themselves, not just an announcement or summary. Therefore, the correct classification is AGM-R with high confidence.
2025-01-16 Chinese
辰欣药业股份有限公司第五届监事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the sixth meeting of the fifth Supervisory Board of the company. It details the meeting's convening, attendance, and the approval of specific proposals such as changes in accounting estimates and the establishment of a public opinion management system. It includes voting results and references to further disclosures on the stock exchange website. The document does not contain full financial statements or detailed financial analysis but is a formal meeting resolution announcement. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or management bodies. The document length is short and focused on meeting resolutions, not a full report or financial release.
2025-01-07 Chinese
辰欣药业股份有限公司关于召开2025年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2025 first extraordinary general meeting of shareholders (临时股东大会) for the company 辰欣药业股份有限公司. It details the meeting date, voting methods, agenda items, registration procedures, and proxy authorization forms. There is no financial data, earnings, or report content included. The document is an announcement informing shareholders about the meeting logistics and agenda, not the actual meeting minutes or voting results. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2025-01-07 Chinese
辰欣药业股份有限公司第五届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board of directors meeting of the company 辰欣药业股份有限公司. It details the meeting date, attendance, and specific agenda items such as changes in accounting estimates, adoption of a public opinion management system, resignation and election of directors, and scheduling of a shareholders meeting. The document includes voting results and references to related announcements on the stock exchange website. There are no financial statements or detailed financial data presented, nor is this a transcript or presentation. The content focuses on board decisions and management changes, particularly the resignation and election of a non-independent director. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 2108 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report. Hence, the classification is MANG with high confidence.
2025-01-07 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.